← Back to Search

Other

Effect of Self-administered Auricular Acupressure on Smoking Cessation-a Pilot Study

Phase 2
Waitlist Available
Led By Lawrence Leung, MD
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly during the intervention period (weeks 1-6) and week 13 and week 26
Awards & highlights
No Placebo-Only Group

Summary

Auricular acupressure has been practiced in China and Germany to help people in smoking cessation programs. The purpose of this clinical trial is to test for the clinical effectiveness of self-administered auricular acupressure as a non-invasive method for smoking cessation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly during the intervention period (weeks 1-6) and week 13 and week 26
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly during the intervention period (weeks 1-6) and week 13 and week 26 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Spot 7-day cessation rate
Secondary study objectives
Adverse effects in terms of self-reported discomfort levels from auricular acupressure
Continuous Cessation Rate (CAR)
End-expiratory carbon monoxide levels (CO)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Arm 2: random points + digital pressure with urgeExperimental Treatment1 Intervention
Arm 2 (20 participants): random points + digital pressure with urge
Group II: Arm 1: NADA points and digital pressureExperimental Treatment1 Intervention
Arm 1: NADA points and digital pressure with urge.
Group III: Arm 3 (20 participants): NO acupressure, only advice + supportActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Queen's UniversityLead Sponsor
375 Previous Clinical Trials
121,693 Total Patients Enrolled
Lawrence Leung, MDPrincipal InvestigatorQueen's University
1 Previous Clinical Trials
116 Total Patients Enrolled
~4 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top